BioCurex Announces Canine Cancer Screening News

BioCurex Inc has announced its wholly owned subsidiary, OncoPet(TM) Diagnostics, Inc., has executed an agreement for the distribution of the OncoPet Sample Collection Kit for canine cancer diagnosis with Butler Schein(TM) Animal Health. Butler Schein Animal Health, a division of Henry Schein (Nasdaq:HSIC), is the leading companion animal health distribution company in the U.S.

According to the agreement, Butler Schein is allowed to purchase the OncoPet Sample Collection Kit from OncoPet Diagnostics to resell to their vast network of veterinary professionals in the United States. The Company has sent Webster Veterinary notice of termination of its previous distribution agreement.

"We are extremely satisfied to have completed a definitive distribution agreement for sales of the OncoPet Sample Collection Kit with Butler Schein," stated Dr. Paul D. Slowey, President of BioCurex. "With the largest animal health distribution company in the U.S. now under agreement with OncoPet, we are confident that our products and services will be comprehensively represented to animal health professionals throughout the largest veterinary market in the world.

Dr. Ricardo Moro, OncoPet's President and BioCurex's CEO added, "It is important to stress the significance of this agreement because the largest distributor of veterinary products in the U.S. knows what sells well and how to make money with the products they carry. Their confidence in the OncoPet RECAF test is a huge endorsement and a clear indication of its commercial potential. The sales force of this company is in the hundreds and our facilities are ready to process any orders resulting from their efforts.